Korea's PPIs market getting heated

The domestic market scale for proton pump inhibitors (PPIs) is estimated at 30.0 billion won, compared with 23.0 billion a year ago.

Major items being offered on the domestic market last year were omeprazole preparations having the sales of 10.0 billion won, followed by rabeprazole preparations with 5.0 billion won, lansoprazole preparations with 3.5 billion won, pantoprazole preparations w...